Antimicrobial‐Resistant Nocardia Isolates, United States, 1995–2004
Clinical Infectious Diseases2010Vol. 51(12), pp. 1445–1448
Citations Over TimeTop 1% of 2010 papers
Kristin Broome Uhde, Sonal Pathak, Isaac McCullum, Deanna Jannat‐Khah, Sean V. Shadomy, Clare A. Dykewicz, Thomas A. Clark, Theresa L. Smith, June M. Brown
Abstract
We conducted a 10-year retrospective evaluation of the epidemiology and identification of Nocardia isolates submitted to the Centers for Disease Control and Prevention for antimicrobial susceptibility testing. The species most commonly identified were N. nova (28%), N. brasiliensis (14%), and N. farcinica (14%). Of 765 isolates submitted, 61% were resistant to sulfamethoxazole and 42% were resistant to trimethoprim-sulfamethoxazole.
Related Papers
- → Silver-coated magnetic nanoparticles as an efficient delivery system for the antibiotics trimethoprim and sulfamethoxazole against E. Coli and S. aureus: release kinetics and antimicrobial activity(2021)24 cited
- → Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim(1981)62 cited
- → Penetration of Trimethoprim and Sulfamethoxazole Into Cysts in a Patient With Autosomal-Dominant Polycystic Kidney Disease(1986)27 cited
- → Trimethoprim-Sulfamethoxazole vs Sulfamethoxazole for Acute Urinary Tract Infections in Children(1978)16 cited
- A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.(1983)